Preview

Медицинский алфавит

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Доступ платный или только для Подписчиков

Эмпирическая и долговременная терапия тазовой боли, связанной с эндометриозом

https://doi.org/10.33667/2078-5631-2021-8-8-12

Полный текст:

Аннотация

Эндометриоз является распространенным заболеванием, диагностика и терапия которого по-прежнему остаются предметом дискуссий Один из главных симптомов эндометриоза - тазовая боль представляет особую проблему в связи со сложностями выявления причины и отсутствием достаточного эффекта от хирургического и медикаментозного лечения. В обзоре литературы представлены современные данные о распространенности, клинической характеристике и методах индивидуального подбора терапии у пациенток с тазовой болью установленно или предположительно ассоциированной с эндометриозом.

Об авторе

И. В. Кузнецова
Научный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени В.И. Кулакова
Россия

Кузнецова Ирина Всеволодовна - доктор медицинских наук, профессор, советник директора.

Москва.



Список литературы

1. Klein S, D'Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? A prospective Belgian study. Reprod Biomed Online. 2014; 28 (1): 116-124. DOI: 10.1016/j.rbmo.2013.09.020.

2. Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012; 27 (5): 1292-1299. DOI: 10.1093/humrep/des073.

3. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10 (5): 261-275. DOI: 10.1038/nrendo.2013.255.

4. Soliman AM, Coyne KS, Zaiser E, Castelli-Haley J, Fuldeore MJ. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosom Obstet Gynaecol. 2017; 38 (4): 238-248. DOI: 10.1080/0167482X.2017.1289512.

5. Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017; 209: 3-7. DOI: 10.1016/j.ejogrb.2016.04.021.

6. Powell J. The approach to chronic pelvic pain in the adolescent. Obstet Gynecol Clin North Am. 2014; 41 (3): 343-355. DOI: 10.1016/j.ogc.2014.06.001.

7. Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest. 2017; 82 (5): 453-461. DOI: 10.1159/000452660.

8. Singh S, Soliman AM, Rahal Y, Robert C, Defoy I, Nisbet P, Leyland N. Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30 000 Women. J Obstet Gynaecol Can. 2020; 42 (7): 829-838. DOI: 10.1016/j.jogc.2019.10.038.

9. Эндометриоз: диагностика, лечение и реабилитация: Федеральные клинические рекомендации по ведению больных. М.: МЗ РФ, 2016.

10. Muzii L, Marana R, Angioli R, Bianchi A, Cucinella G, Vignali M, Benedetti Panici P, Busacca M. Histologic analysis of specimens from laparoscopic endometrioma excision performed by different surgeons: does the surgeon matter? Fertil Steril. 2011; 95 (6): 2116-2119. DOI: 10.1016/j.fertnstert.2011.02.034.

11. Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, As-Sanie S. Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain. Obstet Gynecol 2016; 127 (6): 1045-1053.

12. Gubbels AL, Li R, Kreher D, Mehandru N, Castellanos M, Desai NA, Hibner M. Prevalence of occult microscopic endometriosis in clinically negative peritoneum during laparoscopy for chronic pelvic pain. Int J Gynaecol Obstet. 2020; 151 (2): 260-266. DOI: 10.1002/ijgo.13303.

13. Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215 (5): 589.e1-589.e6. DOI: 10.1016/j.ajog.2016.05.029.

14. Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, Chapron C. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod. 2012; 27: 3294-3303.

15. Sugita A, Iwase A, Goto M, et al. One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? Fertil Steril. 2013; 100 (2): 516-522.e3. DOI: 10.1016/j.fertnstert.2013.03.032.

16. Ferrero S, Scala C, Racca A, Calanni L, Remorgida V, Venturini PL, Leone Roberti Maggiore U. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril. 2015; 103 (5): 1236-1243. DOI: 10.1016/j.fertnstert.2015.01.032.

17. Dunselman GA, Vermeulen N, Becker C, et al; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29 (3): 400-412. DOI: 10.1093/humrep/det457.

18. Sieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescentstriking early to limit suffering: A narrative review. Neurosci Biobehav Rev. 2020; 108: 866-876. DOI: 10.1016/j.neubiorev.2019.12.004.

19. Антоненко М. В., Сапрыкина О. А. Использование агонистов гонадотропных рилизинг-гормонов в терапии эндометриоза. Эффективная фармакотерапия. Акушерство и гинекология. 2012; 1: 34-35.

20. Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update. 2020 Jun 18; 26 (4): 565-585. DOI: 10.1093/humupd/dmaa009.

21. Choi J, Jo M, Lee E, Lee DY, Choi D. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Mol Hum Reprod. 2020; 26 (1): 30-39. DOI: 10.1093/molehr/gaz064.

22. Mita S, Shimizu Y, Sato A, Notsu T, Imada K, Kyo S. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertil Steril. 2013; 101 (2): 595–601. DOI: 10.1016/j.fertnstert.2013.10.038.

23. Miyashita M, Koga K, Takamura M, et al. Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecol Endocrinol 2014; 30 (9): 644-648. DOI: 10.3109/09513590.2014.911279.

24. Takeuchi A, Koga K, Miyashita M, et al. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016; 207: 157-161. DOI: 10.1016/j.ejogrb.2016.10.053.

25. Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, Bono Y, Kyo S. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015; 147: 103-110. DOI: 10.1016/j.jsbmb.2014.12.008.

26. Grandi G, Mueller M, Bersinger NA, Cagnacci A, Volpe A, McKinnon B. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res. 2016; 65 (3): 183-192. DOI: 10.1007/s00011-015-0909-7.

27. Mabrouk M, Paradisi R, Arena A, Del Forno S, Matteucci C, Zannoni L, Caprara G, Seracchioli R. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. Gynecol Endocrinol. 2018; 34 (5): 399-403. DOI: 10.1080/09513590.2017.1405932.

28. Del Forno S, Mabrouk M, Arena A, Mattioli G, Giaquinto I, Paradisi R, Seracchioli R. Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? Eur J Obstet Gynecol Reprod Biol. 2019; 238: 120-124. DOI: 10.1016/j.ejogrb.2019.04.010.

29. Kitajima M, Matsumoto K, Murakami N, Harada A, Kitajima Y, Masuzaki H, Miura K. Ovarian reserve after three-step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study. Reprod Med Biol. 2020; 19 (4): 425-431. DOI: 10.1002/rmb2.12349.

30. Angioni S, Pontis A, Malune ME, Cela V, Luisi S, Litta P, Vignali M, Nappi L. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020; 36 (1): 84-86. DOI: 10.1080/09513590.2019.1640674.

31. Muzii L, Galati G, Di Tucci C, Di Feliciantonio M, Perniola G, Di Donato V, Benedetti Panici P, Vignali M. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020; 36 (1): 81-83. DOI: 10.1080/09513590.2019.1640199.

32. Тихонова Е. С. Медицинские и социальные аспекты генитального эндометриоза: Автореф. дис. ... канд. мед. наук. М., 2013; 26 с.

33. Кузнецова И. В. Эндометриоз и тазовая боль: что мы лечим? О природе болевого синдрома при эндометриозе и возможностях терапии. Status Praesens. Гинекология, акушерство, бесплодный брак. 2015; 1 (27): 50-54.

34. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014; 101 (4): 927-935. DOI: 10.1016/j.fertnstert.2014.02.012.

35. Caruso S, Iraci M, Cianci S, Fava V, Casella E, Cianci A. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 pg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest. 2016; 39 (8): 923-931. DOI: 10.1007/s40618-016-0460-6.

36. Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A, Fedele L. Oral contraceptives and risk of endometriosis: a systematic review and me-ta-analysis. Hum Reprod Update. 2011; 17 (2): 159-170. DOI: 10.1093/humupd/dmq042.

37. Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaoui G, Goffinet F, de Ziegler D. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011; 26 (8): 2028-2035. DOI: 10.1093/humrep/der156.

38. Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018; 51: 68-91. DOI: 10.1016/j.bpobgyn.2018.01.015.


Для цитирования:


Кузнецова И.В. Эмпирическая и долговременная терапия тазовой боли, связанной с эндометриозом. Медицинский алфавит. 2021;(8):8-12. https://doi.org/10.33667/2078-5631-2021-8-8-12

For citation:


Kuznetsova I.V. Empirical and long-term therapy for endometriosis-associated pelvic pain. Medical alphabet. 2021;(8):8-12. (In Russ.) https://doi.org/10.33667/2078-5631-2021-8-8-12

Просмотров: 28


ISSN 2078-5631 (Print)